Evidence map›Paper›PMID 39926115›Full record

ArticleFrontiers in cellular and infection microbiology2024

Epigenome-wide DNA methylation profiling in septic and non-septic patients with similar infections: potential use as sepsis biomarkers.

Ian López-Cruz, José Luis García-Giménez, Manuel Madrazo, Judit García-Guallarte, Laura Piles, Federico V Pallardó, Arturo Artero

Abstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ian López-CruzDepartment of Internal Medicine, Dr. Peset University Hospital, Valencia, Spain.
José Luis García-GiménezDepartment of Physiology, Faculty of Medicine & Dentistry, University of Valencia, Valencia, Spain.
Manuel MadrazoDepartment of Internal Medicine, Dr. Peset University Hospital, Valencia, Spain.
Judit García-GuallarteEpiDisease S.L., Parc Científic de la Universitat de València, Paterna, Spain.
Laura PilesDepartment of Internal Medicine, Dr. Peset University Hospital, Valencia, Spain.
Federico V PallardóDepartment of Physiology, Faculty of Medicine & Dentistry, University of Valencia, Valencia, Spain.
Arturo ArteroDepartment of Internal Medicine, Dr. Peset University Hospital, Valencia, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Sepsis is a life-threatening condition caused by a dysregulated immune response to infection, leading to organ failure. Despite its significant global burden, the underlying mechanisms of immune dysfunction in sepsis remain incompletely understood. This study explores the role of DNA methylation in white blood cells in sepsis pathogenesis. Methods: A prospective case-control study was conducted to compare DNA methylation profiles between patients with community-acquired sepsis and matched controls who had similar infections but did not develop sepsis. Whole blood samples from these patients were analyzed using the Infinium MethylationEPIC v2.0 kit, enabling genome-wide methylation analysis. Selected genes with differential methylation were validated by pyrosequencing. Results: Significant differential DNA methylation patterns were identified between septic and non-septic individuals uising. Our results suggest that DNA methylation changes are closely linked to the pathophysiological processes of sepsis, influencing immune cell activation, inflammation, and organ dysfunction. The most prominent findings include the hypomethylation of immune-related genes ( Discussion: Our results underscore the potential of DNA methylation changes, particularly in immune-related genes, to enhance the early detection of sepsis and to stratify patients based on severity. Future research should explore the therapeutic implications of these epigenetic alterations in sepsis care.

Indexed as

BiomarkersDNA MethylationEpigenomeSepsisAdultAgedalpha 1-AntitrypsinCase-Control StudiesCommunity-Acquired InfectionsEpigenesis, GeneticFemaleHumansLeukocytesMaleMiddle AgedProspective Studiesalpha 1-AntitrypsinBiomarkersSERPINA1 protein, humanbiomarkersDNA methylationepigeneticsimmune systeminflammationsepsisseptic shock

Identifiers

PMID39926115
PMCPMC11802815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.